RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.

Related Reports

Market Research Reports provided by reports.iptechex.com
Withdrawal of Rimonabant and Sibutramine Create High Unmet Need in Obesity Market
Dec 2010 - 4 pages - $500
Obesity Therapy Area Pipeline Report
Nov 2010 - 414 pages - $1,495
Obesity Therapeutics: Understanding market dynamics (presentation)
Apr 2007 - 21 pages - $5,695
Will Anyone Crack the Obesity Drug Market?
Feb 2011 - 102 pages - $2,615
Obesity Market Forecast
Jul 2009 - $15,200
Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical development
Dec 2009 - 90 pages - $3,800
Coldwell Banker Gene Armstrong, Inc. - Company Capsule
Nov 2011 - 6 pages - $75
R&D Trends: Obesity - 2006–2011: obesity’s lean years
May 2011 - 40 pages - $3,800
Company Financials: OSI Pharmaceuticals
Jan 2010 - $75
Gene Signal International SA. – Product Pipeline Review – Q1 2011
Mar 2011 - 34 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Gene therapy del
Therapeutic target
Metabolism del
Obesity del

Browse By

Development phase
Early Stage
Preclinical
Phase I
Phase I/II
Phase II
Phase III
Phase III/IV
Preregistration
Registered

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us